Sort   by:  
 Page size 
UnknownDNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancer.
Not available
S-EPMC12740342 | biostudies-literature
UnknownCardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II).
Not available
S-EPMC7528157 | biostudies-literature
UnknownMedulloblastoma Associated with Down Syndrome: From a Rare Event Leading to a Pathogenic Hypothesis.
Not available
S-EPMC7915142 | biostudies-literature
UnknownLung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRAS<sup>G12C</sup> inhibitors.
Not available
S-EPMC11845285 | biostudies-literature
UnknownTransformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Not available
S-EPMC12481261 | biostudies-literature
UnknownDeterminants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.
Not available
S-EPMC11795382 | biostudies-literature
Sort   by:  
 Page size